Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M101,502Revenue $M34,858Net Margin (%)44.2Altman Z-Score2.0
Enterprise Value $M119,488EPS $1.7Operating Margin %51.0Piotroski F-Score6
P/E(ttm)6.4Beneish M-Score-2.0Pre-tax Margin (%)52.1Higher ROA y-yY
Price/Book8.710-y EBITDA Growth Rate %0.5Quick Ratio1.0Cash flow > EarningsN
Price/Sales2.85-y EBITDA Growth Rate %-5.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow22.7y-y EBITDA Growth Rate %62.7ROA % (ttm)23.4Higher Current Ratio y-yY
Dividend Yield %6.0PEG--ROE % (ttm)173Less Shares Outstanding y-yY
Payout Ratio %38.0Shares Outstanding M2,415ROIC % (ttm)53.3Gross Margin Increase y-yN

Gurus Latest Trades with GSK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GSKCharles Brandes 2015-03-31 Add0.38%$41.68 - $48.81
($45.86)
$ 42.03-8%Add 18.20%3,879,073
GSKNWQ Managers 2015-03-31 Add0.14%$41.68 - $48.81
($45.86)
$ 42.03-8%Add 123.03%456,380
GSKKahn Brothers 2015-03-31 Add0.06%$41.68 - $48.81
($45.86)
$ 42.03-8%Add 14.12%58,200
GSKDodge & Cox 2015-03-31 Reduce-0.02%$41.68 - $48.81
($45.86)
$ 42.03-8%Reduce 2.18%23,436,551
GSKHOTCHKIS & WILEY 2015-03-31 Add0.01%$41.68 - $48.81
($45.86)
$ 42.03-8%Add 0.73%12,302,975
GSKJoel Greenblatt 2015-03-31 Add$41.68 - $48.81
($45.86)
$ 42.03-8%Add 0.41%83,578
GSKKen Fisher 2015-03-31 Reduce$41.68 - $48.81
($45.86)
$ 42.03-8%Reduce 0.07%10,757,080
GSKTweedy Browne 2015-03-31 Reduce$41.68 - $48.81
($45.86)
$ 42.03-8%Reduce 2.19%131,346
GSKDodge & Cox 2014-12-31 Reduce-0.64%$41.3 - $47.14
($44.76)
$ 42.03-6%Reduce 37.91%23,959,301
GSKHOTCHKIS & WILEY 2014-12-31 Add0.21%$41.3 - $47.14
($44.76)
$ 42.03-6%Add 13.04%12,213,885
GSKDavid Dreman 2014-12-31 Sold Out -0.01%$41.3 - $47.14
($44.77)
$ 42.03-6%Sold Out0
GSKDodge & Cox 2014-09-30 Reduce-1.11%$46.29 - $54.52
($49.01)
$ 42.03-14%Reduce 35.93%38,589,161
GSKHOTCHKIS & WILEY 2014-09-30 Add0.98%$46.29 - $54.52
($49.01)
$ 42.03-14%Add 118.31%10,804,564
GSKCharles Brandes 2014-09-30 Add0.56%$46.29 - $54.52
($49.01)
$ 42.03-14%Add 36.63%3,415,717
GSKKahn Brothers 2014-09-30 Buy 0.38%$46.29 - $54.52
($49.01)
$ 42.03-14%New holding51,000
GSKNWQ Managers 2014-09-30 Add0.03%$46.29 - $54.52
($49.01)
$ 42.03-14%Add 39.82%208,125
GSKDavid Dreman 2014-09-30 Buy 0.01%$46.29 - $54.52
($49.01)
$ 42.03-14%New holding1,328
GSKHOTCHKIS & WILEY 2014-06-30 Add0.93%$51.55 - $56.39
($54.16)
$ 42.03-22%Add 13358.60%4,949,118
GSKJohn Rogers 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 42.03-22%Add 49.33%988,772
GSKCharles Brandes 2014-06-30 Add0.21%$51.55 - $56.39
($54.16)
$ 42.03-22%Add 15.52%2,500,048
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GSK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GSK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GLAXOSMITHKLINE PLCFormer 10% Owner 2015-02-23Sell503,150$2292.73view
GLAXOSMITHKLINE PLC10% Owner 2014-12-18Sell50,000$21.14100.57view
GLAXOSMITHKLINE PLCFormer 10% Owner (1) 2014-10-27Sell11,315,825$5.29701.51view
GLAXOSMITHKLINE PLC10% Owner 2014-04-01Buy103,762$12253.33view
GLAXOSMITHKLINE PLCFormer 10% Owner 2014-02-19Buy35,000$14202.86view
GLAXOSMITHKLINE PLCFormer 10% Shareholder 2014-02-10Buy143,773$12253.33view

Quarterly/Annual Reports about GSK:

    News about GSK:

    Articles On GuruFocus.com
    JW1 Jun 28 2015 
    JW1 Jun 28 2015 
    JW1 Jun 28 2015 
    Weekly 3-Year Low Highlights: GSK, TRP, NOV, CHK Jun 15 2015 
    Guru Stocks at 52-Week Lows: XOM, WMT, PG, CVX, GSK Jun 14 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Hotchkis & Wiley Large Cap Value Fund Q1 2015 Commentary May 22 2015 
    Analyst Says GlaxoSmithKline Acquisition Will Benefit Pfizer May 22 2015 
    9 International Dividend Dogs With Upside Potential May 22 2015 
    Endo International Acquires Par Pharmaceuticals For $8 Billion May 21 2015 

    More From Other Websites
    Dow 30 Stock Roundup: Nike Beats Estimates, Verizon Closes AOL Buy - Analyst Blog Jun 26 2015
    GlaxoSmithKline upgraded by Liberum Jun 26 2015
    Glaxo, Pfizer Meningitis B Vaccines Get ACIP's Category B - Analyst Blog Jun 25 2015
    U.S. CDC committee recommends physicians make individual decisions on the use of meningococcal group... Jun 24 2015
    Why Ashmore Group plc, GlaxoSmithKline plc, Keller Group plc & GKN plc Look Set To Charge Higher! Jun 24 2015
    Pfizer to Buy Two Meningitis Vaccines from Glaxo for $130M - Analyst Blog Jun 23 2015
    GSK Vaccinates Pfizer to Gain Novartis - Video Blog Jun 23 2015
    4 Reasons Why GlaxoSmithKline plc Is One Of The Best Dividend Stocks That Money Can Buy! Jun 23 2015
    Pfizer to buy two vaccines from Glaxo Jun 22 2015
    GSK sells two meningitis drugs to Pfizer for £82m Jun 22 2015
    3 Shares Analysts Hate: GlaxoSmithKline plc, Standard Chartered PLC And Anglo American plc Jun 22 2015
    GlaxoSmithKline (GSK) Stock Gains Following Meningitis Vaccines Sale to Pfizer Jun 22 2015
    Pfizer to Acquire Two Meningitis Vaccines Jun 22 2015
    GSK sells two vaccines to Pfizer to ease competition concerns Jun 22 2015
    GSK sells two vaccines to Pfizer to ease competition concerns Jun 22 2015
    Regulatory update on divestment of Nimenrix and Mencevax Jun 22 2015
    How GlaxoSmithKline plc Gave Away $2bn! Jun 19 2015
    British Investigator Says Chinese Officials Tried to Force Confession Jun 18 2015
    Chardan: Sell Axovant Sciences, RVT-101 Market Pricing Is 'Highly Irrational' Jun 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK